Diseases [C] » Nervous System Diseases [C10] » Central Nervous System Diseases » Brain Diseases
Description
Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. MeSH
Hierarchy View
Subtype Terms (32)
Acute Febrile Encephalopathy
25 drugs (14 approved, 11 experimental)
Amblyopia
7 drugs (6 approved, 1 experimental)
Auditory Diseases, Central
5 approved drugs
Basal Ganglia Diseases
7 drugs (1 approved, 6 experimental)
Brain Death
18 drugs (15 approved, 3 experimental)
Brain Edema
22 drugs (19 approved, 3 experimental)
Brain Injuries
101 drugs (81 approved, 20 experimental)
Brain Neoplasms
524 drugs (253 approved, 271 experimental)
Cerebellar Diseases
15 drugs (7 approved, 8 experimental)
Cerebrovascular Disorders
62 drugs (44 approved, 18 experimental)
Dementia
217 drugs (128 approved, 89 experimental)
Diffuse Cerebral Sclerosis of Schilder
1 experimental drug
Encephalitis
35 drugs (24 approved, 11 experimental)
Encephalomalacia
1 approved drug
Epilepsy
165 drugs (111 approved, 54 experimental)
Headache Disorders
18 drugs (13 approved, 5 experimental)
Hydrocephalus
13 drugs (9 approved, 4 experimental)
Hypothalamic Diseases
4 drugs (3 approved, 1 experimental)
Hypoxia, Brain
12 drugs (11 approved, 1 experimental)
Intracranial Hypertension
9 drugs (8 approved, 1 experimental)
Intracranial Hypotension
2 drugs (1 approved, 1 experimental)
Neuroaxonal Dystrophies
2 drugs (1 approved, 1 experimental)
Sepsis-Associated Encephalopathy
3 approved drugs
Approved Indicated Drugs (2)
Phase 4 Indicated Drugs (17)
Phase 2 Indicated Drugs (24)
Phase 1 Indicated Drugs (25)
Other Experimental Indicated Drugs (29)
Organization Involved with Phase 4 Indications (38)
Badalona Hospital Germans Trias i Pujol
Centro Regional para el Estudio de las Enfermedades Digestivas
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Katholieke Universiteit Leuven
Lokmanya Tilak Municipal Medical College
Organization Involved with Phase 3 Indications (70)
All India Institute of Medical Sciences
Case Western Reserve University
Children's National Medical Center
Federal University of Minas Gerais
Helsingin Ja Uudenmaan Sairaanhoitopiirin
Hoosier Cancer Research Network
Mednax Center for Research, Education and Quality
National Health and Medical Research Council, Australia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Norwegian University of Science and Technology
Santa Casa de Misericórdia de Belo Horizonte
The University of Texas, Dallas
University Hospital of North Norway
University of California, San Francisco
Organization Involved with Phase 2 Indications (75)
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Maternal and Child Health Hospital of Hubei Province
Memorial University of Newfoundland
National Cancer Institute (NCI)
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID)
Organization Involved with Phase 1 Indications (33)
Institute for Neurodegenerative Disorders
KK Women's and Children's Hospital
Medical University of South Carolina
National Center for Complementary and Integrative Health (NCCIH)
Organization Involved with Other Experimental Indications (40)
Bethune International Peace Hospital
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Cook Children's Health Care System
Cook Children's Medical Center
Hospital of South West Jutland
Institute of Liver and Biliary Sciences, India
Instituto Mexicano del Seguro Social
Instituto Nacional de Ciencias Medicas de Nutricion
National Institute of Mental Health (NIMH)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
